公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2016 | A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection | JIA-HORNG KAO ; Chien R.-N.; Chang T.-T.; Peng C.-Y.; Hu T.-H.; Lo G.-H.; Wang H.-Y.; Chen J.-J.; Yang J.C.; Knox S.J.; Han L.; Mo H.; Mathias A.; Brainard D.M.; Sheen I.-S.; Hsu Y.-C.; Chu C.-J.; Chuang W.-L. | Liver International | 25 | 25 | |
2015 | A polymorphism in interferon L3 Is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis c virus infection | Chang K.-C.; Tseng P.-L.; Wu Y.-Y.; Hung H.-C.; Huang C.-M.; Lu S.-N.; Wang J.-H.; Lee C.-M.; Chen C.-H.; Tsai M.-C.; Yen Y.-H.; Lin M.-T.; Wu C.-K.; Huang C.-C.; Chen, Tony Hsiu Hsi ; Hu T.-H. | Clinical Gastroenterology and Hepatology | 49 | 47 | |
2021 | Preoperative ALBI grade predicts the outcomes in non-B non-C HCC patients undergoing primary curative resection | YU-CHIEH TSAI ; Sou F.-M.; Liu Y.-W.; Wu Y.-J.; Yong C.-C.; Chen D.-W.; Huang P.-Y.; Cho W.-R.; Chuang C.-H.; Hsiao C.-C.; Hu T.-H.; Tsai M.-C. | BMC Gastroenterology | 6 | 7 | |
2015 | Reply | Chen, Tony Hsiu Hsi ; Yeh Y.-P.; Lao C.-S.; Hu T.-H.; Yen A.M.-F.; Wu W.Y.-Y. | Hepatology | 0 | 0 | |
2021 | Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma | Yang S.-Y.; Wang C.-C.; Chen K.-D.; Liu Y.-W.; Lin C.-C.; Chuang C.-H.; YU-CHIEH TSAI ; Yao C.-C.; Yen Y.-H.; Hsiao C.-C.; Hu T.-H.; Tsai M.-C. | BMC Cancer | 12 | 11 | |
2019 | Taiwan consensus statement on the management of chronic hepatitis B | Chien R.-N.; JIA-HORNG KAO ; Peng C.-Y.; Chen C.-H.; CHUN-JEN LIU ; Huang Y.-H.; Hu T.-H.; Yang H.-I.; Lu S.-N.; YEN-HSUAN NI ; Chuang W.-L.; Lee C.-M.; Wu J.-C.; PEI-JER CHEN ; Liaw Y.-F. | Journal of the Formosan Medical Association | 50 | 47 |